In a year with modest economic growth, it was consolidations, divestments and growing technology bases that were some of the factors that altered rankings among IBO’s list of the top 30 analytical and life science instrument and aftermarket companies for 2012. Among the list’s most notable changes was Illumina’s entry into the top 10 due […]
With 16 of the 18 companies in IBO’s Lab Instrument Sales Index having now reported results for calendar year 2012 fourth quarter, Index sales and operating profit results have been updated from the February 15 issue (see IBO 2/15/13). For the fourth-quarter 2012, Index revenue grew 2.7%, or 3.7% excluding currency, and operating profit slipped […]
Company Announcements Illumina announced in January that its 2013 organic investments will include the addition of 50 sales representatives for improved geographic reach, incremental R&D investments and infrastructure enhancements. Becton, Dickinson and Company appointed Catherine M. Burzik to its Board in January. Most recently, she was CEO of Kinetic Concepts. QIAGEN currency-neutral fourth-quarter 2012 revenues […]
US equity markets trended higher in March, despite financial concerns over sequestration, higher payroll taxes, renewed European debt woes and a sluggish US fourth-quarter GDP growth rate, which was revised slightly higher from 0.1% to 0.4%. Instead, investors focused on the stronger consumer sector, including higher home prices, personal spending and retail sales, which should […]
Company Announcements In January, Anton Paar opened subsidiaries in Poland, South Africa and Brazil. Microwave synthesis and Petrotest products will continue to be distributed in Poland by Comef and Tusnovics, respectively. The South African subsidiary is a joint venture with sales partner Swiss Lab. In January, AMETEK Advanced Measurement Technology acquired Sunpower, a developer of […]
Fourth-quarter 2012 IBO Life Science Index sales grew 6.4%, 6.7% organically, to $3,791 million. Operating profit improved 1.7% to $844 million. Based on continuing operations, operating margin fell 100 basis points to 21.3% of sales. For 2012, Life Science Index sales expanded 4.0%, 4.2% organically, to $13,534 million. Operating profit grew 1.6% to $2,870 million. […]
New York, NY 3/7/13—At its annual investors meeting, Agilent Technologies announced that it will exit its OEM and Specialty magnets business. The business, which it had acquired when it bought Varian (see IBO 7/31/09), makes super high-end magnets for research and other applications. Nick Roelofs, president of Agilent’s Life Sciences Group, told the conference, “This […]
This year, three major, publicly held analytical companies are implementing structural changes designed to advance their strategic and financial goals. The changes reflect the companies’ growing sizes and their ability to capitalize on financial and market opportunities. Scanning electron microscopy maker FEI announced in January that it has reorganized into two groups: the Industry Group […]
Federal agencies and laboratory instrument companies are now bracing for the effects of sequestration. On March 1, the Office of Management and Budget (OMB) officially announced fiscal 2013 (FY13) across-the-board reductions to all federal US agencies (see IBO 11/30/11). The $85 billion total budget cuts for FY13 are part of the Budget Control Act of […]
US equity markets vacillated for most of February. However, rising confidence over sustained quantitative easing measures for the foreseeable future overshadowed most of the sequestration concerns. In addition, better-than-expected consumer confidence, an improved housing market and positive manufacturing momentum helped drive the Dow Jones Industrial Average and S&P 500 up 1.4% and 1.1% for the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
